APO RESEARCH · REPORT
Allergy Immunotherapies
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
Product & engineering
Understand the product.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
Selected research
Industry Research
Allergy Immunotherapies Industry Research Report 2026
Market perspective
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In Southeast Asia Allergy Immunotherapies key players include ALK, Stallergenes, etc. Southeast Asia top two manufacturers hold a share about 65%.
Read the full market overview
Singapore is the largest market, with a share over 30%, followed by Thailand and Malaysia, both have a share about 35 percent.
In terms of product, Subcutaneous Immunotherapy is the largest segment, with a share about 43%. And in terms of application, the largest application is Allergic Rhinitis, followed by Allergic Asthma, etc.
Report Scope
This report quantifies the global Allergy Immunotherapies market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Allergy Immunotherapies.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Allergy Immunotherapies Market by Company
ALK
Stallergenes
HAL
Allergy Immunotherapies Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Allergy Immunotherapies Segment by Application
Allergic Rhinitis
Allergic Asthma
Other
Allergy Immunotherapies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Allergy Immunotherapies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Allergy Immunotherapies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Allergy Immunotherapies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Allergy Immunotherapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Subcutaneous Immunotherapy
- Sublingual Immunotherapy
Applications
- Allergic Rhinitis
- Allergic Asthma
- Other
Companies covered
- ALK
- Stallergenes
- HAL
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Allergy Immunotherapies by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Subcutaneous Immunotherapy
- 2.2.3 Sublingual Immunotherapy
- 2.3 Allergy Immunotherapies by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Allergic Rhinitis
- 2.3.3 Allergic Asthma
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Allergy Immunotherapies Breakdown Data by Type
- 3.1 Global Allergy Immunotherapies Historic Market Size by Type (2021-2026)
- 3.2 Global Allergy Immunotherapies Forecasted Market Size by Type (2027-2032)
4 Allergy Immunotherapies Breakdown Data by Application
- 4.1 Global Allergy Immunotherapies Historic Market Size by Application (2021-2026)
- 4.2 Global Allergy Immunotherapies Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Allergy Immunotherapies Market Perspective (2021-2032)
- 5.2 Global Allergy Immunotherapies Growth Trends by Region
- 5.2.1 Global Allergy Immunotherapies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Allergy Immunotherapies Historic Market Size by Region (2021-2026)
- 5.2.3 Allergy Immunotherapies Forecasted Market Size by Region (2027-2032)
- 5.3 Allergy Immunotherapies Market Dynamics
- 5.3.1 Allergy Immunotherapies Industry Trends
- 5.3.2 Allergy Immunotherapies Market Drivers
- 5.3.3 Allergy Immunotherapies Market Challenges
- 5.3.4 Allergy Immunotherapies Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Allergy Immunotherapies Players by Revenue
- 6.1.1 Global Top Allergy Immunotherapies Players by Revenue (2021-2026)
- 6.1.2 Global Allergy Immunotherapies Revenue Market Share by Players (2021-2026)
- 6.2 Global Allergy Immunotherapies Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Allergy Immunotherapies Head Office and Area Served
- 6.4 Global Allergy Immunotherapies Players, Product Type & Application
- 6.5 Global Allergy Immunotherapies Manufacturers Established Date
- 6.6 Global Allergy Immunotherapies Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Allergy Immunotherapies Market Size (2021-2032)
- 7.2 North America Allergy Immunotherapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Allergy Immunotherapies Market Size by Country (2021-2026)
- 7.4 North America Allergy Immunotherapies Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Allergy Immunotherapies Market Size (2021-2032)
- 8.2 Europe Allergy Immunotherapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Allergy Immunotherapies Market Size by Country (2021-2026)
- 8.4 Europe Allergy Immunotherapies Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Allergy Immunotherapies Market Size (2021-2032)
- 9.2 Asia-Pacific Allergy Immunotherapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Allergy Immunotherapies Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Allergy Immunotherapies Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Allergy Immunotherapies Market Size (2021-2032)
- 10.2 South America Allergy Immunotherapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Allergy Immunotherapies Market Size by Country (2021-2026)
- 10.4 South America Allergy Immunotherapies Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Allergy Immunotherapies Market Size (2021-2032)
- 11.2 Middle East & Africa Allergy Immunotherapies Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Allergy Immunotherapies Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Allergy Immunotherapies Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 ALK
- 12.1.1 ALK Company Information
- 12.1.2 ALK Business Overview
- 12.1.3 ALK Revenue in Allergy Immunotherapies Business (2021-2026)
- 12.1.4 ALK Allergy Immunotherapies Product Portfolio
- 12.1.5 ALK Recent Developments
- 12.2 Stallergenes
- 12.2.1 Stallergenes Company Information
- 12.2.2 Stallergenes Business Overview
- 12.2.3 Stallergenes Revenue in Allergy Immunotherapies Business (2021-2026)
- 12.2.4 Stallergenes Allergy Immunotherapies Product Portfolio
- 12.2.5 Stallergenes Recent Developments
- 12.3 HAL
- 12.3.1 HAL Company Information
- 12.3.2 HAL Business Overview
- 12.3.3 HAL Revenue in Allergy Immunotherapies Business (2021-2026)
- 12.3.4 HAL Allergy Immunotherapies Product Portfolio
- 12.3.5 HAL Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst